Girndt J, Kramer A, Scheler F
Klin Wochenschr. 1977 Apr 1;55(7):349-50. doi: 10.1007/BF01488115.
Preexisting increase of plasma renin activity in hypertension seems to indicate an effective hypotensive action of adrenergic beta-receptor antagonists. In spite of marked elevation of plasma renin activity in Goldblatt-rats, the beta-blocker Pindolol failed to lower the blood pressure. On the contrary, high doses of this substance led to an acceleration of the Goldblatt-type hypertension, perhaps because of the intrinsic sympathomimetic activity of Pindolol. These findings support the conception that beta-blockers are effective in lowering the blood pressure only in hypertension with stimulated renin secretion, which is caused by an increased activity of the sympathetic nervous system. Plasma renin activity was not altered by Pindolol. There existed a linear relationship between blood pressure and left-ventricular weight in all groups of rats, which was not impaired by Pindolol in all used doses.
高血压患者中预先存在的血浆肾素活性升高似乎表明肾上腺素能β受体拮抗剂具有有效的降压作用。尽管戈德布拉特大鼠的血浆肾素活性显著升高,但β受体阻滞剂吲哚洛尔未能降低血压。相反,高剂量的这种物质导致戈德布拉特型高血压加速,这可能是由于吲哚洛尔的内在拟交感活性。这些发现支持了这样一种观点,即β受体阻滞剂仅在交感神经系统活性增加导致肾素分泌受刺激的高血压中有效降低血压。吲哚洛尔未改变血浆肾素活性。所有大鼠组的血压与左心室重量之间存在线性关系,所有使用剂量的吲哚洛尔均未损害这种关系。